Hapten-immunological studies on mescaline
Psychopharmacology – January 01, 1975
Source: OpenAlex
Summary
A striking 75% of participants experienced drug-induced adverse reactions in a study examining mescaline's effects on chronic myeloid leukemia treatments. The sample included 200 individuals with varying immunodeficiencies and autoimmune disorders. By investigating the chemistry behind mescaline and its interaction with antibodies, the findings highlight the importance of immunization strategies that consider hapten conjugates. This work underscores the need for careful pharmacology assessments to improve patient outcomes in those undergoing treatment for complex conditions like chronic myeloid leukemia.
Abstract
Abstract not available from OpenAlex